Akari Therapeutics slides 21% despite WuXi XDC backing its drug program.
Share this article
Markets
Score 35
Bearish
Akari Therapeutics slides 21% despite WuXi XDC backing its drug program
Apr 06, 2026 15:09 UTC
AKTX
Immediate term
Related Articles
Score 35
Walmart's Digital Price Tags Spark Debate Over Efficiency and Consumer Impact
Apr 06, 16:50
Score 35
IWR ETF Sees Strong Inflows Amid Market Volatility
Apr 06, 16:42
Score 25
VBIL ETF Sees Notable Inflow Amid Market Volatility
Apr 06, 16:42
Score 35
VGSH Sees Notable Inflows Amid Bond Market Activity
Apr 06, 16:42
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.